Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,2 USD | +0,84% | -3,23% | +14,29% |
Omzet 2024 * | 7,76 mln. 7,25 mln. | Omzet 2025 * | 8,69 mln. 8,13 mln. | Marktkapitalisatie | 85,52 mln. 79,98 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -73 mln. -68,27 mln. | Nettowinst (verlies) 2025 * | -70 mln. -65,47 mln. | EV/omzet 2024 * | 1,84 x |
Nettoliquiditeiten 2024 * | 71,24 mln. 66,63 mln. | Nettoliquiditeiten 2025 * | 157 mln. 147 mln. | EV/omzet 2025 * | -8,28 x |
K/w-verhouding 2024 * |
-1,23
x | K/w-verhouding 2025 * |
-1,32
x | Werknemers | 89 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,23% |
Recentste transcriptie over Aclaris Therapeutics, Inc.
1 dag | +0,84% | ||
1 week | -3,23% | ||
Lopende maand | -3,23% | ||
1 maand | -4,76% | ||
3 maanden | -2,44% | ||
6 maanden | -72,85% | ||
Lopend jaar | +14,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 01-07-12 |
Kevin Balthaser
DFI | Director of Finance/CFO | - | 01-01-17 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 09-08-17 |
Maxine Gowen
BRD | Director/Board Member | 66 | 02-07-19 |
Andrew Powell
BRD | Director/Board Member | 66 | 25-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.08% | 0 M€ | 0,00% | - | |
0.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,2 | +0,84% | 445 216 |
25-04-24 | 1,19 | +1,71% | 1 626 758 |
24-04-24 | 1,17 | -4,10% | 1 439 407 |
23-04-24 | 1,22 | 0,00% | 637 744 |
22-04-24 | 1,22 | -1,61% | 663 173 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,29% | 85,52 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |